Furthermore, captopril treatment reduced complement C3 production in astrocytes while inhibiting C3–C3ar signaling-mediated glial activation, potentially preventing synaptic loss, epileptogenesis, and cognitive impairment. Here, C3AR1 is linked to Cognitive impairment.